Recruiting
Phase 1

A Study of MGD024 in Patients With Relapsed or Refractory Hematologic Malignancies

Sponsor:

MacroGenics

Code:

NCT05362773

Conditions

Leukemia, Acute Myeloid

Myelodysplastic Syndromes

Classical Hodgkin Lymphoma

Leukemia, B-cell

Leukemia, Hairy Cell

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

MGD024

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information